ScinoPharm Taiwan Ltd

Common Name
ScinoPharm Taiwan
Country
Taiwan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
1789
Exchange
TAIWAN STOCK EXCHANGE
Description
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emp...

ScinoPharm Taiwan's Climate Target Data Preview

As of 2024, ScinoPharm Taiwan has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into ScinoPharm Taiwan ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Download Data

Verified Sources Behind ScinoPharm Taiwan’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ScinoPharm Taiwan’s data sources below and access millions more through our Disclosure Search.

a. ScinoPharm Taiwan's Sustainability Report 2024
a. ScinoPharm Taiwan's Sustainability Report 2024

Insights into ScinoPharm Taiwan's Greenhouse Gas Emissions Pathways

As of 2024, ScinoPharm Taiwan has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a

Does ScinoPharm Taiwan have a target to reduce the emissions from its operations?

As of 2024, ScinoPharm Taiwan has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a

ScinoPharm Taiwan's most ambitious operational target is to reduce these emissions by 42% by 2030, compared to a baseline of 37,799.847 Metric Tonnes of CO2 equivalent (mtCO2e) in 2023. a

As of 2024, ScinoPharm Taiwan is ahead of schedule on its operational emissions reduction target, having achieved 43.62% of the planned reduction. a

ScinoPharm Taiwan's Operational (Scope 1+2) Emissions Pathway

20232024203009.5 k19 k28.5 k38 kBaselineCurrent (-18%)Target 2030 (-42%)
Want Full Access to ScinoPharm Taiwan's Climate Targets Dataset?
Sign Up